Summary Parkinson’s disease with mild cognitive impairment (PD-MCI) is a common non-motor manifestation that severely impairs functional independence and quality of life. A single-blind randomized controlled trial was conducted to evaluate whether mindfulness combined with cognitive-motor dual-task training (CMDT) improves multidimensional outcomes in patients with PD-MCI. Fifty three...
Advanced ScienceSeptember 25, 2025Ye Wang, Lei Liu, Jinghao Wang et al.2 citations
Current pharmacotherapies for post-traumatic stress disorder (PTSD) are limited by delayed onset and side effects. Despite ketamine exhibiting rapid relief of the core symptoms of PTSD, its clinical efficacy varies considerably depending on the timing of drug delivery. However, the underlying mechanism remains unclear. In this study, the therapeutic effects of early (day 1) and late (day 7)...
Objectives: (R)-ketamine hydrochloride injection is a novel, rapid-acting antidepressant for the treatment of treatment-resistant depression. The aim of this study was to assess the pharmacokinetics, safety, and tolerability of (R)-ketamine hydrochloride injection in healthy Chinese subjects following ascending single intravenous doses ranging from 10.0 mg to 180 mg. Methods: This randomized,...
Brain SciencesNovember 22, 2022Shanshan Liu, Yuan Jia, Sisi Zheng et al.
The self-perception or self-experience of patients with depersonalization/derealization disorder (DPD) is altered, leading to a profound disruption in self-awareness. The main aim of the study is to explore the characteristics of subliminal self-face processing in DPD patients. To our knowledge, this is the first experimental study that has measured and evaluated subliminal self-processing in...